Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
Abstract The precise pathogenesis of immune-related diseases remains unclear, and new effective therapeutic choices are required for the induction of remission or cure in these diseases. Basic research utilizing immune-related disease patient-derived induced pluripotent stem (iPS) cells is expected...
Main Authors: | Hirofumi Shoda, Bunki Natsumoto, Keishi Fujio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41232-023-00303-4 |
Similar Items
-
Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases
by: Takayuki Tanaka, et al.
Published: (2022-05-01) -
Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis
by: Samuel Gagne, et al.
Published: (2023-08-01) -
Vasculitis in Systemic Autoinflammatory Diseases
by: Selcan Demir, et al.
Published: (2018-12-01) -
Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease
by: Ioana Saulescu, et al.
Published: (2022-11-01) -
Histologic Patterns and Clues to Autoinflammatory Diseases in Children: What a Cutaneous Biopsy Can Tell Us
by: Athanassios Kolivras, et al.
Published: (2021-06-01)